Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics in Infectious Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics in Infectious Disease Testing. This report contains market size and forecasts of Molecular Diagnostics in Infectious Disease Testing in global, including the following market information:
Global Molecular Diagnostics in Infectious Disease Testing Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Molecular Diagnostics in Infectious Disease Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.
We surveyed the Molecular Diagnostics in Infectious Disease Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnostics in Infectious Disease Testing Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Molecular Diagnostics in Infectious Disease Testing Market Segment Percentages, by Type, 2022 (%)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others
Global Molecular Diagnostics in Infectious Disease Testing Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Molecular Diagnostics in Infectious Disease Testing Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Academic Institutes
Laboratories
Others
Global Molecular Diagnostics in Infectious Disease Testing Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Molecular Diagnostics in Infectious Disease Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Diagnostics in Infectious Disease Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Molecular Diagnostics in Infectious Disease Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
BD
BioMerieux
Thermo Fisher Scientific
Roche
Siemens
Veridex
Luminex
GenMark Diagnostics
Qiagen
Genomix Biotech
BioTheranostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Diagnostics in Infectious Disease Testing, market overview.
Chapter 2: Global Molecular Diagnostics in Infectious Disease Testing market size in revenue.
Chapter 3: Detailed analysis of Molecular Diagnostics in Infectious Disease Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Diagnostics in Infectious Disease Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics in Infectious Disease Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnostics in Infectious Disease Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics in Infectious Disease Testing Overall Market Size
2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size: 2022 VS 2035
2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnostics in Infectious Disease Testing Players in Global Market
3.2 Top Global Molecular Diagnostics in Infectious Disease Testing Companies Ranked by Revenue
3.3 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnostics in Infectious Disease Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Diagnostics in Infectious Disease Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics in Infectious Disease Testing Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnostics in Infectious Disease Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics in Infectious Disease Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Diagnostics in Infectious Disease Testing Market Size Markets, 2022 & 2035
4.1.2 Polymerase Chain Reaction (PCR)
4.1.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
4.1.4 Microarrays
4.1.5 Next-Generation Sequencing (NGS)
4.1.6 Hybridization
4.1.7 Others
4.2 By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2023
4.2.2 By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2024-2035
4.2.3 By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnostics in Infectious Disease Testing Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Academic Institutes
5.1.5 Laboratories
5.1.6 Others
5.2 By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2023
5.2.2 By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2024-2035
5.2.3 By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics in Infectious Disease Testing Market Size, 2022 & 2035
6.2 By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2023
6.2.2 By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2024-2035
6.2.3 By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2035
6.3.2 US Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.3.3 Canada Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.3.4 Mexico Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2035
6.4.2 Germany Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4.3 France Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4.4 U.K. Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4.5 Italy Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4.6 Russia Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4.7 Nordic Countries Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4.8 Benelux Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2035
6.5.2 China Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.5.3 Japan Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.5.4 South Korea Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.5.5 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.5.6 India Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2035
6.6.2 Brazil Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.6.3 Argentina Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2035
6.7.2 Turkey Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.7.3 Israel Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.7.4 Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.7.5 UAE Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
7 Molecular Diagnostics in Infectious Disease Testing Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.1.4 Abbott Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 BD
7.2.1 BD Company Summary
7.2.2 BD Business Overview
7.2.3 BD Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.2.4 BD Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.2.5 BD Key News & Latest Developments
7.3 BioMerieux
7.3.1 BioMerieux Company Summary
7.3.2 BioMerieux Business Overview
7.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.3.4 BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.3.5 BioMerieux Key News & Latest Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.4.4 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.4.5 Thermo Fisher Scientific Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.5.4 Roche Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Siemens
7.6.1 Siemens Company Summary
7.6.2 Siemens Business Overview
7.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.6.4 Siemens Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.6.5 Siemens Key News & Latest Developments
7.7 Veridex
7.7.1 Veridex Company Summary
7.7.2 Veridex Business Overview
7.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.7.4 Veridex Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.7.5 Veridex Key News & Latest Developments
7.8 Luminex
7.8.1 Luminex Company Summary
7.8.2 Luminex Business Overview
7.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.8.4 Luminex Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.8.5 Luminex Key News & Latest Developments
7.9 GenMark Diagnostics
7.9.1 GenMark Diagnostics Company Summary
7.9.2 GenMark Diagnostics Business Overview
7.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.9.4 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.9.5 GenMark Diagnostics Key News & Latest Developments
7.10 Qiagen
7.10.1 Qiagen Company Summary
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.10.4 Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.10.5 Qiagen Key News & Latest Developments
7.11 Genomix Biotech
7.11.1 Genomix Biotech Company Summary
7.11.2 Genomix Biotech Business Overview
7.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.11.4 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.11.5 Genomix Biotech Key News & Latest Developments
7.12 BioTheranostics
7.12.1 BioTheranostics Company Summary
7.12.2 BioTheranostics Business Overview
7.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.12.4 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.12.5 BioTheranostics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Molecular Diagnostics in Infectious Disease Testing Market Opportunities & Trends in Global Market
Table 2. Molecular Diagnostics in Infectious Disease Testing Market Drivers in Global Market
Table 3. Molecular Diagnostics in Infectious Disease Testing Market Restraints in Global Market
Table 4. Key Players of Molecular Diagnostics in Infectious Disease Testing in Global Market
Table 5. Top Molecular Diagnostics in Infectious Disease Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Molecular Diagnostics in Infectious Disease Testing Product Type
Table 9. List of Global Tier 1 Molecular Diagnostics in Infectious Disease Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnostics in Infectious Disease Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Molecular Diagnostics in Infectious Disease Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Molecular Diagnostics in Infectious Disease Testing Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Molecular Diagnostics in Infectious Disease Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Molecular Diagnostics in Infectious Disease Testing Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2024-2035
Table 30. Abbott Company Summary
Table 31. Abbott Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 32. Abbott Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Key News & Latest Developments
Table 34. BD Company Summary
Table 35. BD Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 36. BD Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 37. BD Key News & Latest Developments
Table 38. BioMerieux Company Summary
Table 39. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 40. BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 41. BioMerieux Key News & Latest Developments
Table 42. Thermo Fisher Scientific Company Summary
Table 43. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 44. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 45. Thermo Fisher Scientific Key News & Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 48. Roche Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Siemens Company Summary
Table 51. Siemens Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 52. Siemens Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Siemens Key News & Latest Developments
Table 54. Veridex Company Summary
Table 55. Veridex Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 56. Veridex Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 57. Veridex Key News & Latest Developments
Table 58. Luminex Company Summary
Table 59. Luminex Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 60. Luminex Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 61. Luminex Key News & Latest Developments
Table 62. GenMark Diagnostics Company Summary
Table 63. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 64. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 65. GenMark Diagnostics Key News & Latest Developments
Table 66. Qiagen Company Summary
Table 67. Qiagen Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 68. Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 69. Qiagen Key News & Latest Developments
Table 70. Genomix Biotech Company Summary
Table 71. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 72. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 73. Genomix Biotech Key News & Latest Developments
Table 74. BioTheranostics Company Summary
Table 75. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 76. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn) & (2018-2023)
Table 77. BioTheranostics Key News & Latest Developments
List of Figures
Figure 1. Molecular Diagnostics in Infectious Disease Testing Segment by Type in 2022
Figure 2. Molecular Diagnostics in Infectious Disease Testing Segment by Application in 2022
Figure 3. Global Molecular Diagnostics in Infectious Disease Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Molecular Diagnostics in Infectious Disease Testing Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2022
Figure 8. By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
Figure 9. By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
Figure 10. By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
Figure 12. By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
Figure 14. By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
Figure 15. By Country - North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
Figure 16. US Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
Figure 20. Germany Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 21. France Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
Figure 28. China Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 32. India Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
Figure 34. Brazil Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
Figure 37. Turkey Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2018-2035
Figure 41. Abbott Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BD Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Siemens Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Veridex Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Luminex Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
